Letter - Visumbureau-Limburgwordpress.visumbureau-limburg.nl/wp-content/... · Web viewPlease...
21
Supplementary material List of the analyzed trials 1- Eder JP Jr, Garcia-Carbonero R, Clark JW, Supko JG, Puchalski TA, Ryan DP, et al. A phase I trial of daily oral 4’-N-benzoyl- staurosporine in combination with protracted continuous infusion 5- fluorouracil in patients with adavanced solid malignancies. Invest New Drugs 2004;22:139-50 2- Le LH, Erlichamn C, Pillon L, Thiessen JJ, Day A, Wainman N, et al. Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days. Invest New Drugs 2004;22:159-67 3- Gelmon K, Hirte H, Fischer B, Walsh W, Ptaszynski M, Hamilton M, et al. A phase 1 study of OSI-211 given as intravenous infusion days 1,2 and 3 every three weeks in patients with solid cancers. Invest New Drugs 2004;22:263-75 4- Hutson TE, Ganapathi R, Elson P, Mekhail T, Olencki T, Budd GT, et al. Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma. Invest New Drugs 2004;22:277-84 5- Curry EA III, Murry DJ, Yoder C, Fife K, Armstrong V, Nakshatri H, et al. Phase I dose escalation of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs 2004;22:299-305 6- Hoff PM, Saad ED, Pazdur R, Wolff R, Lassere Y, Bogaard KR, Abbruzzese JL. Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer. Invest New Drugs 2004;22:307-13 7- Majhail NS, Hussein M, Olencki TE, Budd GT, Wood L, Elson P, et al. Phase I trial of continuous infusion recombiant human interleukin-4 in patients with cancer. Invest New Drugs 2004;22:421-26 8- Chang SM, Kuhn J, Wen P, Greenberg H, Schiff D, Conrad C, et al. Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs 2004;22:427-35 9- Schwartz GH, Jones CB, Garrison M, Patnaik A, Takimoto C, McGreery H, et al. A phase I and pharmacokinetic study of the nonpolyglutamable thymidylate synthetase inihibitor ZD9331 plus docetaxel in patients with adavanced solid malignancies. Invest New Drugs 2004;22:437-48 10- Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJ. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs 2004;22:449-58 11- Marshall JL, Kindler H, Deeken J, Bhargava P, Vogelzang NJ, Rizvi N, et al. Phase I trial of orally administered CEP- 701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor. Invest New Drugs 2005;23:31-7 12- Bjarnason GA, Charpentier D, Wong R, Goel R, Douglas L, Wlsh w, et al. Phase I study of tomudex and doxorubicin in patients with locally advanced inoperable or metastatic cancer (IND.98) Invest New Drugs 2005;23:51-6 13- El-Rayes BF, Ibrahim D, Shields AF, LoRusso PM, Zalupski MM, Philip PA. Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors. Invest New Drugs 2005;23:57-62 14- Goel R, Chouinard E, Stewart DJ, Huan s, Hirte H, Stafford S, et al. An NCIC CTG phaseI/pharmacokinetic study of matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin. Invest New Drugs 2005;23:63-71 1
Letter - Visumbureau-Limburgwordpress.visumbureau-limburg.nl/wp-content/... · Web viewPlease kindly issue a single-/double-/multiple-entry visa to facilitate her/his business trip(s)
Example of invitation, should be printed on letterhead paper of the inviting party. (Including name, contact telephone number, address, stamp, signature of the legal representative or individual)
Place …… , Date ……..
Invitation
Consulate of ChinaVisa DepartmentThe Hague
TO WHOM IT MAY CONCERN,
We, …………….., would like to invite …… to come to China for (purpose of visit)…. from …… to ……at ……….(location)
Detailed information of the invited person:
Surname: .Given names: .Gender: .Passport number: .Date of issue: .Expiry date: .Nationality: .Date of birth: .Job title: .
Invitation should contain information regarding the relationship between the applicant and the inviting party and details of any financial support to be provided during the stay in China.
Please kindly issue a single-/double-/multiple-entry visa to facilitate her/his business trip(s) into China.
Thank you very much for your kind assistance in advance.
Yours sincerely,
Name of inviterJob titleInviter’s direct phone number Stamp and signature
